“Axis recommends Biocon as a technical buy for May, targeting ₹427-448 (11.4% upside) from a buying range of ₹375-385, with a stop loss at ₹359. This technical call is made despite the company reporting a 63% YoY fall in Q4 net profit due to exceptional charges.”

Axis Securities Analysis’s track record: 3 graded calls · 95% CI 21–94%